🇫🇷
France · FR · FR:68238848
DILTIAZEM TEVA L.P. 300 mg, gélule à libération prolongée
ReimbursedATC C05AE03
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerTEVA SANTE
CountryFR (France)
ATC codeC05AE03
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip133400936160033plaquette(s) PVC-Aluminium de 28 gélule(s)EUR 4.95
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "68238848",
"date_amm": "2000-04-12",
"type_amm": "Procédure nationale",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "gélule à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code C05AE03.
- GBAdizem-SR 120mg capsulesLexon (UK) Ltd
- GBAdizem-SR 120mg capsulesDE Pharmaceuticals
- GBAdizem-SR 120mg capsulesMawdsley-Brooks & Company Ltd
- GBAdizem-SR 120mg capsulesWaymade Healthcare Plc
- GBAdizem-SR 120mg capsulesNapp Pharmaceuticals Ltd
- GBAdizem-SR 120mg tabletsNapp Pharmaceuticals Ltd
- GBAdizem-SR 120mg tabletsLexon (UK) Ltd
- GBAdizem-SR 180mg capsulesNapp Pharmaceuticals Ltd
Access this data programmatically
Query DILTIAZEM TEVA L.P. 300 mg, gélule à libération prolongée and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.